Showing results (411-420 of 1,585) with videos related to
Sort By:
Pageof 159
RSC Medicinal Chemistry|April 18, 2022
Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-a]pyridine analoguesYogesh Mahadu Khetmalis, Surendar Chitti, Anjani Umarani Wunnava, et al.RSC Medicinal Chemistry|April 18, 2022
Concise synthesis and biological activity evaluation of novel pyrazinyl-aryl urea derivatives against several cancer cell lines, which can especially induce T24 apoptotic and necroptotic cell deathJia-Nian Chen, Chu-Ting Chen, Yue-Zhen He, et al.RSC Medicinal Chemistry|April 18, 2022
Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeuticsHari Madhav, Ehtesham Jameel, Mohammad Rehan, et al.RSC Medicinal Chemistry|October 21, 2021
Identification of a Zika NS2B epitope as a biomarker for severe clinical phenotypesFelix F Loeffler, Isabelle F T Viana, Nico Fischer, et al.RSC Medicinal Chemistry|October 21, 2021
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarksNeha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.RSC Medicinal Chemistry|October 21, 2021
Small molecule-mediated induction of endoplasmic reticulum stress in cancer cellsShalini Pandey, Virender Kumar Sharma, Ankur Biswas, et al.RSC Medicinal Chemistry|March 21, 2022
Antibacterial activities of plant-derived xanthonesXiaojia Liu, Jianzhong Shen, Kui ZhuRSC Medicinal Chemistry|March 21, 2022
Design, synthesis, and biological evaluation of C6-difluoromethylenated epoxymorphinan Mu opioid receptor antagonistsAndrew J Kassick, Anny Treat, Nestor Tomycz, et al.RSC Medicinal Chemistry|March 21, 2022
A concise review on hPXR ligand-recognizing residues and structure-based strategies to alleviate hPXR transactivation riskTao Liu, James P Beck, Junliang HaoPageof 159